Peripheral blood monocytes as a therapeutic target for marrow stromal cells in stroke patients
BackgroundSystemic administration of marrow stromal cells (MSCs) leads to the release of a broad range of factors mediating recovery in rodent stroke models. The release of these factors could depend on the various cell types within the peripheral blood as they contact systemically administered MSCs...
Main Authors: | Nikunj Satani, Kaushik Parsha, Courtney Davis, Adrian Gee, Scott D. Olson, Jaroslaw Aronowski, Sean I. Savitz |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2022.958579/full |
Similar Items
-
Proteomic Profiling of the Human Fetal Multipotent Mesenchymal Stromal Cells Secretome
by: Arseniy A. Lobov, et al.
Published: (2020-11-01) -
Intrapericardial Administration of Secretomes from Menstrual Blood-Derived Mesenchymal Stromal Cells: Effects on Immune-Related Genes in a Porcine Model of Myocardial Infarction
by: María Ángeles de Pedro, et al.
Published: (2022-05-01) -
Evaluation of transport conditions for autologous bone marrow-derived mesenchymal stromal cells for therapeutic application in horses
by: Miguel Espina, et al.
Published: (2016-03-01) -
Contrariety of Human Bone Marrow Mesenchymal Stromal Cell Functionality in Modulating Circulatory Myeloid and Plasmacytoid Dendritic Cell Subsets
by: Crystal C. Uwazie, et al.
Published: (2023-05-01) -
Acute Myeloid Leukemia Causes Serious and Partially Irreversible Changes in Secretomes of Bone Marrow Multipotent Mesenchymal Stromal Cells
by: Aleksandra Sadovskaya, et al.
Published: (2023-05-01)